Cardiovascular Inflammation Analysis Global Clinical Trials 2013: Worldwide Industry Latest Market Share, Growth, Size,Trends, Strategy And Forecast Research Report 2013
Albany, NY (PRWEB) September 26, 2013 -- "Cardiovascular Inflammation Global Clinical Trials Review, H2, 2013" provides data on the Cardiovascular Inflammation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiovascular Inflammation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The Databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiovascular Inflammation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/cardiovascular-inflammation-global-clinical-trials-review-h2-2013 .
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-Pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/174363 .
Table of Content
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Cardiovascular Inflammation 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Cardiovascular Inflammation 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Cardiovascular Inflammation Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Teijin Pharma Limited 35
Clinical Trial Overview of Teijin Pharma Limited 35
Genentech, Inc. 36
Clinical Trial Overview of Genentech, Inc. 36
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
TNO Pharma 39
Clinical Trial Overview of TNO Pharma 39
Innovaderm Research Inc. 40
Clinical Trial Overview of Innovaderm Research Inc. 40
RNL BIO Co., Ltd. 41
Clinical Trial Overview of RNL BIO Co., Ltd. 41
Troikaa Pharmaceuticals Ltd. 42
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd. 42
Janssen Biotech, Inc. 43
Clinical Trial Overview of Janssen Biotech, Inc. 43
Anthera Pharmaceuticals Inc. 44
Clinical Trial Overview of Anthera Pharmaceuticals Inc. 44
Cumberland Pharmaceuticals, Inc. 45
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 45
Pluristem Therapeutics Inc. 46
Clinical Trial Overview of Pluristem Therapeutics Inc. 46
UMC Utrecht Holding BV 47
Clinical Trial Overview of UMC Utrecht Holding BV 47
Immunomedics, Inc. 48
Clinical Trial Overview of Immunomedics, Inc. 48
Robert Bosch GmbH 49
Clinical Trial Overview of Robert Bosch GmbH 49
Human Genome Sciences, Inc. 50
Clinical Trial Overview of Human Genome Sciences, Inc. 50
Clinical Trial Overview of Top Institutes / Government 51
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Assistance Publique - Hopitaux de Paris 52
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 52
University of Pennsylvania 53
Clinical Trial Overview of University of Pennsylvania 53
Cambridge University Hospitals NHS Foundation Trust 54
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 54
National Heart, Lung, and Blood Institute 55
Clinical Trial Overview of National Heart, Lung, and Blood Institute 55
University of Oxford 56
Clinical Trial Overview of University of Oxford 56
Ministry of Health, Labour and Welfare, Japan 57
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 57
Azienda Sanitaria Locale Carbonia 58
Clinical Trial Overview of Azienda Sanitaria Locale Carbonia 58
Johns Hopkins University 59
Clinical Trial Overview of Johns Hopkins University 59
Duke University 60
Clinical Trial Overview of Duke University 60
National Eye Institute 61
Clinical Trial Overview of National Eye Institute 61
Leiden University Medical Center 62
Clinical Trial Overview of Leiden University Medical Center 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
University Hospital, Toulouse 64
Clinical Trial Overview of University Hospital, Toulouse 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
University of Sao Paulo 66
Clinical Trial Overview of University of Sao Paulo 66
Mayo Clinic 67
Clinical Trial Overview of Mayo Clinic 67
University Medical Center Groningen 68
Clinical Trial Overview of University Medical Center Groningen 68
University Hospitals Birmingham NHS Foundation Trust 69
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 69
Griffith University 70
Clinical Trial Overview of Griffith University 70
Five Key Clinical Profiles 71
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/174363 .
Appendix 153
Abbreviations 153
Definitions 153
Research Methodology 154
Secondary Research 154
About GlobalData 155
Contact Us 155
Disclaimer 155
Source 155
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Cardiovascular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Cardiovascular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Cardiovascular Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Cardiovascular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
Cardiovascular Inflammation Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
Cardiovascular Inflammation Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Cardiovascular Inflammation Therapeutics Clinical Trials, G7 Countries, 2013* 17
Cardiovascular Inflammation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Cardiovascular Inflammation Therapeutics Clinical Trials, E7 Countries, 2013* 19
Cardiovascular Inflammation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Cardiovascular Inflammation Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Cardiovascular Inflammation Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Cardiovascular Inflammation Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 32
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 33
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 34
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Pharma Limited, 2013* 35
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013* 36
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 37
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 38
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by TNO Pharma, 2013* 39
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2013* 40
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by RNL BIO Co., Ltd., 2013* 41
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2013* 42
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2013* 43
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals Inc., 2013* 44
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2013* 45
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2013* 46
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2013* 47
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2013* 48
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch GmbH, 2013* 49
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Human Genome Sciences, Inc., 2013* 50
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 51
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 52
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 53
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2013* 54
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 55
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 56
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2013* 57
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Sanitaria Locale Carbonia, 2013* 58
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 59
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 60
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2013* 61
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 62
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 63
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2013* 64
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 65
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2013* 66
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 67
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 68
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2013* 69
Cardiovascular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Griffith University, 2013* 70
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Cardiovascular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Cardiovascular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Cardiovascular Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Cardiovascular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
Cardiovascular Inflammation Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
Cardiovascular Inflammation Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Cardiovascular Inflammation Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Cardiovascular Inflammation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Cardiovascular Inflammation Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Cardiovascular Inflammation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Cardiovascular Inflammation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29
Cardiovascular Inflammation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
GlobalData Methodology 154
Latest Reports:
China Waste Heat Utilization Equipment Industry Report, 2013-2015: http://www.marketresearchreports.biz/analysis-details/china-waste-heat-utilization-equipment-industry-report-2013-2015
China has rich waste heat resources. Especially in steel, nonferrous, chemical, cement, building materials, oil & petrochemical, light industry, coal and other sectors, waste heat resources approximately occupy 17%-67% of the total fuel consumption, of which, recyclable waste heat resource roughly stand up 60% of the total waste heat resources. At present, China’s waste heat utilization ratio is rather low, with the figure in large steel enterprises being 30%-50%. But the waste heat utilization in other sectors is even lower. Thus, China is expected to see a huge potential to improve its waste heat utilization.
By temperature of waste heat, the waste heat utilization equipments fall into two categories: the first comes to waste heat boiler which uses medium-and high-temperature waste heat; the second refers to lithium bromide refrigerator (heat pump) and screw expander, both of which use low-temperature waste heat. Of these, waste heat boiler occupies a lion’s share in waste heat utilization equipments. In 2012, the output of waste heat boiler approximated 812 sets, totaling 39,788 steam tons.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/175307
Technology Trends in Lubricants (Mineral, Synthetic, and Bio-based) Market for Turbine Oil, Compressor Oil, Gear Oil, Hydraulic Oil, Bearing Oil and Heat Transfer Fluid Lubricant Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018: http://www.marketresearchreports.biz/analysis-details/technology-trends-in-lubricants-mineral-synthetic-and-bio-based-market-for-turbine-oil-compressor-oil-gear-oil-hydraulic-oil-bearing-oil-and-heat-transfer-fluid-lubricant-applications-global-industry-analysis-size-share-growth-trends-a
Synthetic and bio-based lubricants are the major emerging lubricant products. This study highlights and explores key technology trends of synthetic, bio-based and mineral lubricants across a wide range of applications including turbine oil, compressor oil, gear oil, hydraulic oil, heat transfer fluids and bearing oil lubricants. Some of the major qualities that differentiate between lubricants include viscosity index, water separation characteristics, thermal and oxidation stability, low volatility and low carbon formation, and anticorrosion.
This market research report, analyzes the global consumption for lubricants, estimating and forecasting the market from the consumption point of view. The lubricants market has been segmented on the basis of products, applications and geography in order to provide a holistic picture of the market. Market data for all product segments has been provided on a regional level for the period 2011 to 2018. Technology trends have been provided for applications to give an overall idea about the latest happenings in the market. A comprehensive competitive landscape including company market share analysis has also been provided in this analysis.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/175269 .
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://mresearchreports.blogspot.com
Michell Thoras, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article